Pyrogen Testing Market Size, Share and Global Trend By Test (Oncology Monocyte Activation Test (MAT), Limulus Amebocyte Lysate (LAL), Rabbit Pyrogen Test Recombinant Factor C Assay (RFC), In Vitro Pyrogen Test), By Product (Instruments, Consumables), By End User (Food & Beverage Companies, Medical Devices Companies, Pharmaceuticals Companies, Biotechnology Companies & Others), and Regional Forecast, 2024-2032

Pyrogen is an agent or substance, usually biological in nature, which causes fever. Pyrogen can be classified into two categories: endogenous pyrogen and exogenous pyrogen. Endogenous pyrogen is released due to phagocytosis, wherein bacteria are ingested by phagocytes, a special cell, which protects the body from harmful agents. The released endogenous pyrogen acts upon the brain’s hypothalamus, increasing the body’s temperature.

Increased demand for pyrogen testing products in the pharmaceutical and biotechnology industry and rising investments in research and development for pyrogen testing kits are some of the factors expected to drive the growth of the global pyrogen testing market.

The increasing prevalence of chronic and infectious diseases, and strict regulations for the pharmaceuticals and medical devices manufacturers for pyrogen testing, are some of the factors expected to drive the growth of the global pyrogen testing market. Rapidly growing pharmaceutical industry in emerging countries, and increasing emphasis of regulatory authorities for pyrogen testing are some of the factors expected to drive the growth of the global pyrogen testing market during the forecast period.

KEY PLAYERS COVERED

Some of the major companies that are present in the global pyrogen testing market are Charles River, Associates of Cape Cod, Inc., Sanquin, GenScript, Hyglos GmbH, Ellab A/S, Merck KGaA, Wako USA, Lonza and WuXi AppTec., and others.

SEGMENTATION

KEY INSIGHTS

Recent industry developments such as partnerships, mergers, and acquisitions

Regulatory framework by key regions

Pricing analysis by key regions

REGIONAL ANALYSIS 

The market for pyrogen testing is dominated by North America, owing to the number of factors such as the prevalence of the chronic and infectious diseases, better regulatory framework, high presence of pharmaceutical and other companies and the advancements in research and development. The presence of well-developed healthcare infrastructure, well-defined rules, and regulations for pharmaceutical manufacturing process should help North America to dominate the market share in the forecast period. Asia Pacific is anticipated to grow at a significant CAGR during the forecast period due to the lesser stringency in government regulations for drug development.